iBio, Inc. (IBIO)
NASDAQ·Healthcare·Biotechnology
$1.67
-2.34%
Mkt Cap $27.00M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 10, 2026 | $50.00K | — | — | -$0.08 | -$0.09 | -12.50% | — | — |
| Q4 2025 Nov 12, 2025 | $33.33K | $100.00K | +200.00% | -$0.07 | -$0.11 | -57.14% | — | — |
| Q3 2025 Sep 5, 2025 | $100.00K | $200.00K | +100.00% | -$0.39 | -$0.31 | +20.51% | — | — |
| Q2 2025 May 2, 2025 | $66.67K | — | — | -$0.39 | -$0.49 | -25.64% | — | — |
| Q1 2025 Feb 10, 2025 | — | $200.00K | — | -$0.45 | -$0.48 | -6.67% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.46 | -$0.46 | +0.00% | — | — |
| Q3 2024 Sep 25, 2024 | — | $175.00K | — | -$0.47 | -$0.91 | -93.62% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | — | -$0.71 | — | — | — |
| Q1 2024 Feb 9, 2024 | — | — | — | — | -$2.42 | — | — | — |
| Q4 2023 Nov 14, 2023 | — | $50.00K | — | — | -$4.20 | — | — | — |
| Q3 2023 Sep 27, 2023 | $200.00K | — | — | -$0.41 | $0.26 | +163.41% | — | — |
| Q2 2023 May 11, 2023 | $200.00K | $200.00K | +0.00% | -$3.42 | -$6.61 | -93.36% | — | — |
| Q1 2023 Feb 14, 2023 | $600.00K | — | — | -$146.90 | -$21.60 | +85.30% | — | — |
| Q4 2022 Nov 14, 2022 | $600.00K | $56.00K | -90.67% | -$1.85 | -$2.05 | -10.81% | — | — |
| Q4 2022 Oct 11, 2022 | $250.00K | $61.00K | -75.60% | -$2.12 | -$1.96 | +7.55% | — | — |
| Q2 2022 May 12, 2022 | $200.00K | $1.94M | +871.50% | -$1.25 | -$30.00 | -2300.00% | — | — |
| Q1 2022 Feb 14, 2022 | $250.00K | $168.00K | -32.80% | -$1.00 | -$25.00 | -2400.00% | — | — |
| Q4 2021 Nov 15, 2021 | $300.00K | $211.00K | -29.67% | -$1.25 | -$20.00 | -1500.00% | — | — |
| Q3 2021 Sep 27, 2021 | — | $491.00K | — | — | -$25.00 | — | — | — |
| Q2 2021 May 17, 2021 | $918.00K | $765.00K | -16.67% | -$1.25 | -$20.00 | -1500.00% | — | — |